Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital

M Cecilia Di Pentima1, Shannon Chan

  • 1Division of Infectious Diseases, Department of Pediatrics, Alfred I. duPont Hospital for Children, Wilmington, DE, USA. cdipenti@nemours.org

Insights

An Antimicrobial Stewardship Program significantly reduced vancomycin use and prescribing errors in a pediatric hospital. This initiative improved care quality and safety for hospitalized children by optimizing antibiotic utilization.

Area of Science:

  • Infectious Diseases
  • Pediatric Pharmacology
  • Healthcare Management

Background:

  • Rising rates of resistant gram-positive coccal infections necessitated increased vancomycin use.
  • Evaluating the impact of Antimicrobial Stewardship Programs (ASPs) on vancomycin utilization is crucial.

Purpose of the Study:

  • To assess the effect of an ASP on vancomycin use density in a pediatric tertiary-care teaching hospital.
  • To identify and reduce vancomycin prescribing errors.

Main Methods:

  • Implementation of an ASP with mandatory vancomycin indication fields in the information system.
  • Real-time review of vancomycin prescriptions by an infectious disease pharmacist and physician.
  • Monitoring vancomycin use density (doses/1000 patient-days) and prescription errors.

Main Results:

  • Vancomycin use density decreased from 378 to 255 doses/1000 patient-days.
  • Despite increased Staphylococcus aureus infections, vancomycin prescribing errors, including dosing and premature discontinuation, decreased post-ASP implementation.
  • Non-approved vancomycin indications were noted in 28% of doses before interventions.

Conclusions:

  • An integrated ASP effectively reduced vancomycin utilization and prescribing errors.
  • Real-time feedback and system optimization improved the quality and safety of pediatric care.
  • ASP implementation is a valuable strategy for optimizing antibiotic use in pediatric settings.
Abstract

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...